Christoph Rentsch

Christoph Rentsch is an expert in private and public funding markets and an executive corporate finance leader with more than 25 years of experience in the life science field. He started his career in investment banking and worked in senior management functions for the Alusuisse-Lonza Group both in Switzerland and in the USA. In 1994 he returned to Switzerland to join Roche as Head Group Funding and Capital Markets, taking responsibility for worldwide finance transactions of the Roche Group. In 2004 he co-founded Caperis AG, a life science investment management firm. From 2010-2020 he was CFO of Polyphor (2010) and Santhera Pharmaceuticals (2015). Since 2020 he is a Venture Partner at Independent Capital Group and Executive Bord member of TargImmune Therapeutics.

Christoph Rentsch holds a Master’s Degree in Economics and Business Administration from the University of Applied Sciences in Basel, Switzerland.